Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Change in Accured Expenses (2020 - 2023)

Historic Change in Accured Expenses for Terns Pharmaceuticals (TERN) over the last 4 years, with Q4 2023 value amounting to $772000.0.

  • Terns Pharmaceuticals' Change in Accured Expenses fell 4281.48% to $772000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $2.7 million, marking a year-over-year increase of 9272.6%. This contributed to the annual value of $4.2 million for FY2024, which is 5551.48% up from last year.
  • As of Q4 2023, Terns Pharmaceuticals' Change in Accured Expenses stood at $772000.0, which was down 4281.48% from $6000.0 recorded in Q3 2023.
  • Terns Pharmaceuticals' 5-year Change in Accured Expenses high stood at $2.7 million for Q1 2023, and its period low was -$3.9 million during Q1 2021.
  • Its 4-year average for Change in Accured Expenses is $347375.0, with a median of $398500.0 in 2022.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first crashed by 70000.0% in 2021, then skyrocketed by 476666.67% in 2022.
  • Over the past 4 years, Terns Pharmaceuticals' Change in Accured Expenses (Quarter) stood at -$77000.0 in 2020, then tumbled by 700.0% to -$616000.0 in 2021, then soared by 319.16% to $1.3 million in 2022, then crashed by 42.81% to $772000.0 in 2023.
  • Its Change in Accured Expenses was $772000.0 in Q4 2023, compared to $6000.0 in Q3 2023 and -$715000.0 in Q2 2023.